Copyright: ©Author(s) 2026.
World J Clin Oncol. Mar 24, 2026; 17(3): 116062
Published online Mar 24, 2026. doi: 10.5306/wjco.v17.i3.116062
Published online Mar 24, 2026. doi: 10.5306/wjco.v17.i3.116062
Table 4 Reproductive outcomes, n (%)
| Outcome | |
| ART use | 37 (31.6) |
| Pregnancy achieved | 68 (58.1) |
| Live birth | 59 (50.4) |
| Miscarriage | 9 (13.2 of pregnancies) |
| Ectopic | 0 (0) |
| Obstetric complications | 5 (8.5 of live births) |
| Post-pregnancy hysterectomy | 28 (47.5 of live births) |
- Citation: Jamil A, Sughra G, Abbasi GD, Adane S, Punshi M, Muhammad MG, Nausherwan M, Ishtiaq Y, Hazoor MD. Oncologic safety and reproductive outcomes of conservative therapy for early-stage endometrial disease. World J Clin Oncol 2026; 17(3): 116062
- URL: https://www.wjgnet.com/2218-4333/full/v17/i3/116062.htm
- DOI: https://dx.doi.org/10.5306/wjco.v17.i3.116062